VAERS Explorer
Back to explore

Report #2856020

Received Aug 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NJ
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1—OT
HPV9HPV (GARDASIL 9)MERCK & CO. INC.2—OT
HPV9HPV (GARDASIL 9)MERCK & CO. INC.3—OT

Symptoms (3)

ColposcopyHuman papilloma virus test positiveInappropriate schedule of product administration

Symptom narrative

patient has tested positive for HPV; irst dose of GARDASIL 9 in 2019, their second in 2024 and their third 6 months later; This spontaneous report was received from a Physician and refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. In 2019, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), then in 2024 she received the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), and 6 months later, she received the third dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) (Inappropriate schedule of vaccine administration). No lot # and expiration date were not reported for any dose, all administered by Unknown route for human papilloma virus (HPV). On an unknown date, HPV test showed Positive. Patient has had a colposcopy; however results were unknown at time of report. At the reporting time, the outcome of the event was unknown. The causal relationship between the event of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) was not reported. Batch/Lot number is being requested and will be submitted if received.

Lab data

Test Name: HPV Test; Test Result: Positive